Skip to main content

Table 2 Postoperative clinical course

From: The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery

Ā 

Group T

(nā€‰=ā€‰27)

Group C

(nā€‰=ā€‰30)

p value

Mortality, n (%)a

0 (0Ā %)

0 (0Ā %)

-

Duration of intensive care unit stay (days)

1.3ā€‰Ā±ā€‰1.9

1.2ā€‰Ā±ā€‰1.3

0.816

Bleeding amount (mL)

324.2ā€‰Ā±ā€‰273.4

308.4ā€‰Ā±ā€‰202.3

0.804

Intubation time (hours)

9.3ā€‰Ā±ā€‰5.3

11.2ā€‰Ā±ā€‰6.4

0.230

Perioperative adverse events, n (%)

ā€ƒNeurological complications, n (%)

0 (0Ā %)

0 (0Ā %)

-

ā€ƒArrhythmia, n (%)

6 (22.2Ā %)

8 (26.7Ā %)

0.697

ā€ƒRenal replacement therapy, n (%)

0 (0Ā %)

0 (0Ā %)

-

ā€ƒRIFLE classification-Risk, n (%)

1 (3.7Ā %)

4 (13.3Ā %)

0.467

  1. aThe observation period for mortality was 2.9Ā years (mean 2.1Ā years)